COMMUNIQUÉS West-GlobeNewswire

-
Anika Reports First Quarter 2024 Financial Results
08/05/2024 -
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
08/05/2024 -
Terns Pharmaceuticals Announces Leadership Changes
08/05/2024 -
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
08/05/2024 -
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
08/05/2024 -
RadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA(1) and Adjusted Earnings(3) and Revises Upwards 2024 Financial Guidance Ranges
08/05/2024 -
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
08/05/2024 -
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
08/05/2024 -
Surrozen Provides First Quarter 2024 Financial Results and Business Update
08/05/2024 -
electroCore Announces First Quarter 2024 Financial Results
08/05/2024 -
Apollomics Announces Private Placement Financing and Addition to Board of Directors
08/05/2024 -
LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance
08/05/2024 -
RxSight, Inc. Announces Proposed Public Offering of Common Stock
08/05/2024 -
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
08/05/2024 -
Maravai LifeSciences Reports First Quarter 2024 Financial Results
08/05/2024 -
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
08/05/2024 -
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
08/05/2024 -
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
08/05/2024 -
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis
08/05/2024
Pages